When you see this type of data with the existing treatments for GVHD; Ryoncil’s long term data is simply outstanding, with both efficacy & safety.
The FDA cannot ignore Ryoncil!
GL MSB’ers - onwards & upwards
When you see this type of data with the existing treatments for...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.06 |
Change
0.010(0.96%) |
Mkt cap ! $1.210B | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.07 | $1.04 | $1.488M | 1.417M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 84939 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.06 | 74618 | 14 |
View Market Depth
| Last trade - 10.55am 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.06 |
Change
0.010 ( 1.83 %) |
||||
| Open | High | Low | Volume | ||
| $1.04 | $1.07 | $1.04 | 193787 | ||
| Last updated 11.14am 14/05/2024 ? | |||||
| MSB (ASX) Chart |